Document is current
Any future updates will be listed below
-
Authors
Ronaldson-Bouchard, Kacey
Teles, Diogo http://orcid.org/0000-0002-0235-6583
Yeager, Keith
Tavakol, Daniel Naveed http://orcid.org/0000-0003-0451-0617
Zhao, Yimu
Chramiec, Alan
Tagore, Somnath
Summers, Max
Stylianos, Sophia
Tamargo, Manuel
Lee, Busub Marcus
Halligan, Susan P. http://orcid.org/0000-0003-4311-9688
Abaci, Erbil Hasan
Guo, Zongyou
Jacków, Joanna
Pappalardo, Alberto
Shih, Jerry
Soni, Rajesh K.
Sonar, Shivam
German, Carrie
Christiano, Angela M.
Califano, Andrea http://orcid.org/0000-0003-4742-3679
Hirschi, Karen K. http://orcid.org/0000-0001-7116-0130
Chen, Christopher S. http://orcid.org/0000-0003-2445-8449
Przekwas, Andrzej
Vunjak-Novakovic, Gordana http://orcid.org/0000-0002-9382-1574
-
Funding
Funding for this research was provided by:
National Science Foundation (DGE1644869, NSF16478, NSF16478)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA197745S10)
U.S. Department of Health & Human Services | National Institutes of Health (OD012351, S10 OD021764)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (UG3EB025765)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA249799)
- License Information
-
More Information
Article History
Received: 8 July 2020
Accepted: 11 March 2022
First Online: 27 April 2022
Competing interests
: G.V.-N. is a co-founder and board director of epiBone, Tara Biosystems, Xylyx Bio and Immplacate and holds equity in all four companies. K.R-B. and Y.Z. are co-founders of TARA Biosystems and hold equity in the company. S.P.H. holds equity in Xylyx Bio. An.C. is founder, equity holder and consultant of DarwinHealth, Inc., a company that has licensed some of the algorithms used in this manuscript from Columbia University. Columbia University is also an equity holder in DarwinHealth, Inc. The other authors declare no competing interests.
